2022
DOI: 10.1016/j.jbi.2021.103973
|View full text |Cite
|
Sign up to set email alerts
|

High-quality gene/disease embedding in a multi-relational heterogeneous graph after a joint matrix/tensor decomposition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 34 publications
0
4
0
Order By: Relevance
“…Notably, this area also features a different school of approaches that involve node embedding in heterogeneous networks spanning genes, diseases, chemicals, etc. Notable among these is the work by Zhou et al (2022) , which provides ∼11.2 two million putative disease–gene connections. A similar work by Yang et al (2019) used disease-related (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Notably, this area also features a different school of approaches that involve node embedding in heterogeneous networks spanning genes, diseases, chemicals, etc. Notable among these is the work by Zhou et al (2022) , which provides ∼11.2 two million putative disease–gene connections. A similar work by Yang et al (2019) used disease-related (e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Node2vec 10 also converts nodes into embedding vectors, demonstrating that it is better to learn continuous feature vectors rather than constant feature vectors. Similarly, in bioinformatics, gene embedding has been used to represent genes 11 16 . Most of these methods have been developed for entity relationship prediction; e.g., protein–protein, protein–drug, drug–disease, and drug-side-effect interactions 14 16 .…”
Section: Introductionmentioning
confidence: 99%
“…Similarly, in bioinformatics, gene embedding has been used to represent genes 11 16 . Most of these methods have been developed for entity relationship prediction; e.g., protein–protein, protein–drug, drug–disease, and drug-side-effect interactions 14 16 . Because these entity relationship prediction tasks do not predict sample-specific information (e.g., drug response and survival time prediction), sample-specific datasets such as gene expression data were not used yet.…”
Section: Introductionmentioning
confidence: 99%
“…Heterogeneous data interaction was also modelled by Huang et al 19 for predicting transcription factor interactions with their target genes. Wang 20 and Zhou 21 instead, modelled gene-disease interactions trough a heterogenous-network model. Other recent problems solved through heterogeneous graph-based models include Gene Ontology Representation Learning, 22 Gene prioritization for rare diseases 23 and drug repurposing.…”
Section: Introductionmentioning
confidence: 99%